Filing Details
- Accession Number:
- 0001683168-17-001394
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-05-24 15:10:08
- Reporting Period:
- 2017-05-22
- Filing Date:
- 2017-05-24
- Accepted Time:
- 2017-05-24 15:10:08
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1355790 | International Stem Cell Corp | ISCO.OB | Pharmaceutical Preparations (2834) | 204494098 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1447708 | Andrey Semechkin | C/O International Stem Cell Corp. 5950 Priestly Drive Carlsbad CA 92008 | Chief Executive Officer | Yes | Yes | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2017-05-22 | 3,200 | $1.64 | 1,528,450 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 53,334 | Indirect | Bu Corporation |
Footnotes
- Common Stock is owned by X-Master, Inc., a New Hampshire Corporation of which the reporting person is a sole shareholder.